Ramat Hasharon, Israel

Shmuel Bukshpan

This inventor holds 14 USPTO granted patents and 14 published patent applications and 3 EPO patents. Top assignees: Minovia Therapeutics Ltd., Protein Forest, Inc., Cellect Technologies Corp.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shmuel Bukshpan. Retrieved from https://idiyas.com/inventor/shmuel-bukshpan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 64.3

 

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 218(Granted Patents)


Company Filing History:


Years Active: 2003-2026

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Shmuel Bukshpan: Innovator in Mitochondrial Augmentation Therapy

Introduction

Shmuel Bukshpan is a prominent inventor based in Ramat Hasharon, Israel. He has made significant contributions to the field of mitochondrial augmentation therapy, focusing on treatments for brain and renal diseases. With a total of 14 patents to his name, Bukshpan's work is paving the way for innovative therapeutic approaches.

Latest Patents

Among his latest patents, Bukshpan has developed groundbreaking methods for treating brain diseases through mitochondrial augmentation therapy. His invention provides stem cells enriched with healthy functional mitochondria, along with pharmaceutical compositions that utilize these cells. This therapy aims to address brain diseases, disorders, and symptoms, regardless of whether they are associated with acquired mitochondrial dysfunction. Additionally, he has created a similar therapeutic approach for renal diseases, offering new hope for patients suffering from these conditions.

Career Highlights

Shmuel Bukshpan has worked with Minovia Therapeutics Ltd., where he has been instrumental in advancing research and development in mitochondrial therapies. His expertise and innovative mindset have positioned him as a key figure in this emerging field.

Collaborations

Bukshpan has collaborated with notable professionals in his field, including Uriel Halavee and Natalie Yivgi Ohana. These partnerships have further enhanced his research and contributed to the success of his inventions.

Conclusion

Shmuel Bukshpan's work in mitochondrial augmentation therapy represents a significant advancement in medical science. His innovative patents and collaborations are set to make a lasting impact on the treatment of brain and renal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…